FDA greenlights Life Biosciences' gene therapy study to rewind the age of cells
One of the biggest theories about the cause of aging, and how to slow and potentially even reverse it, is about to be put to the test.
Life Biosciences, a biotech startup co-founded by Harvard ...
⚠️ 风险分析 中
摘要：FDA批准基因疗法研究，涉及知识产权和数据合规风险。
影响：企业需确保临床试验符合FDA法规，保护患者数据隐私，并管理知识产权以避免侵权纠纷。
建议：加强临床试验合规审查，实施数据保护措施，并评估知识产权布局。
「素履以往」
Not the sharpest mind, but the steadiest hand.
Not the sharpest mind, but the steadiest hand.